HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reina Ohba Selected Research

phosphatidyl-N-monomethylaminoethanol

8/2017A Retrospective Study, an Initial Lesion of Primary Malignant Melanoma of the Esophagus Revealed by Endoscopy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Reina Ohba Research Topics

Disease

7Inflammation (Inflammations)
05/2007 - 02/2005
6Ulcer
02/2018 - 02/2005
3Neoplasms (Cancer)
02/2020 - 10/2007
2Neoplasm Metastasis (Metastasis)
02/2020 - 02/2018
2Peripheral Vascular Diseases (Peripheral Vascular Disease)
05/2007 - 01/2006
1Infections
01/2022
1Pain (Aches)
01/2022
1Hepatocellular Carcinoma (Hepatoma)
02/2018
1Actinomycosis
02/2018
1Melanoma (Melanoma, Malignant)
08/2017
1Stomach Neoplasms (Stomach Cancer)
09/2016
1Squamous Cell Neoplasms (Squamous Cell Cancer)
02/2014
1Duodenal Ulcer (Curling's Ulcer)
01/2013
1Diarrhea
01/2013
1Fistula
01/2013
1Carcinoid Tumor (Carcinoid)
03/2008
1Atrophic Gastritis
03/2008
1Crohn Disease (Crohn's Disease)
01/2007
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2006
1Carcinogenesis
08/2006
1Acute Liver Failure (Fulminant Hepatic Failure)
05/2005
1Body Weight (Weight, Body)
05/2005

Drug/Important Bio-Agent (IBA)

3Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
09/2006 - 05/2005
3ATL 146eIBA
01/2006 - 02/2005
2Pharmaceutical PreparationsIBA
10/2007 - 11/2006
2CytokinesIBA
05/2007 - 01/2006
2Phosphodiesterase InhibitorsIBA
05/2007 - 01/2006
2Cilostazol (Pletal)FDA LinkGeneric
05/2007 - 01/2006
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
05/2007 - 01/2006
2Cyclic AMP (AMP, Cyclic)IBA
09/2006 - 06/2005
1Pepsinogen A (Pepsinogen)IBA
01/2022
1Z 338IBA
01/2022
1Anaplastic Lymphoma KinaseIBA
02/2020
1Ampicillin (Omnipen)FDA LinkGeneric
02/2018
1Anti-Bacterial Agents (Antibiotics)IBA
02/2018
1phosphatidyl-N-monomethylaminoethanolIBA
08/2017
1Biomarkers (Surrogate Marker)IBA
09/2016
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2007
1ProstaglandinsIBA
02/2007
1AcidsIBA
02/2007
1TRPV Cation ChannelsIBA
02/2007
1Infliximab (Remicade)FDA Link
01/2007
1polaprezinc (Z 103)IBA
11/2006
1HSP72 Heat-Shock ProteinsIBA
11/2006
1NF-kappa B (NF-kB)IBA
11/2006
1Acetic Acid (Vinegar)FDA LinkGeneric
11/2006
1Biological ProductsIBA
08/2006
1Heat-Shock Proteins (Heat-Shock Protein)IBA
08/2006
1Purinergic P1 Receptors (Adenosine Receptor)IBA
01/2006
1RolipramIBA
06/2005
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2005
1LipopolysaccharidesIBA
05/2005
1GalactosamineIBA
05/2005
1Adenosine (Adenocard)FDA LinkGeneric
02/2005

Therapy/Procedure

1Oral Administration
02/2018
1Drug Therapy (Chemotherapy)
02/2018
1Esophagectomy
03/2014
1Chemoradiotherapy
02/2014
1Gastroenterostomy
01/2013
1Gastrectomy
01/2013
1Kidney Transplantation
03/2008
1Therapeutics
11/2006